This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Giri, D. Articles by Ittmann, M. Search for Related Content PubMed PubMed Citation Articles by Giri, D. Articles by Ittmann, M.

Alterations in Expression of Basic Fibroblast Growth Factor (FGF) 2 and Its Receptor FGFR-1 in Human Prostate Cancer¹

Department of Pathology, Baylor College of Medicine and Houston Department of Veterans Affairs Medical Center, Houston, Texas 77030

Fibroblast growth factors (FGFs) play an important role in the growth and maintenance of the normal prostate. There is increasing evidence from both animal models and analysis of human prostate cancer cell lines that alterations of FGFs and/or FGF receptors (FGFRs) may play an important role in prostate cancer progression. To better define the role of FGF2 and FGF7 in human prostate cancer in vivo, we have quantified these two growth factors in clinically localized human prostate cancers and uninvolved prostate by ELISA and Western blotting and determined their localization by immunohistochemistry. The expression of two of the primary receptors for these growth factors, FGFR-1 and FGFR-2, were also analyzed by immunohistochemistry and Western blotting in these same samples. We have found that FGF2 is significantly increased in prostate cancers when compared with uninvolved prostate and that the FGF2 is present in the stromal fibroblasts and endothelial cells but not the cancer cells. In addition, we have observed overexpression of both FGFR-1 and FGFR-2 in the prostate cancer epithelial cells in a subset of prostate cancers and that such overexpression is correlated with poor differentiation. Thus, there is both an increase in FGF2 concentration in prostate cancers and an increased expression of a receptor capable of responding to this growth factor, establishing a potential paracrine stimulation of prostate cancer cells by the surrounding stromal cells, which may play an important role in prostate cancer progression.

This article has been cited by other articles:

				L. M. Cotton, M. K. O'Bryan, and B. T. Hinton Cellular Signaling by Fibroblast Growth Factors (FGFs) and Their Receptors (FGFRs) in Male Reproduction Endocr. Rev., April 1, 2008; 29(2): 193 - 216. [Abstract] [Full Text] [PDF]

				M. P.V. Shekhar, S. Santner, K. A. Carolin, and L. Tait Direct Involvement of Breast Tumor Fibroblasts in the Modulation of Tamoxifen Sensitivity Am. J. Pathol., May 1, 2007; 170(5): 1546 - 1560. [Abstract] [Full Text] [PDF]

				Y. Lin, G. Liu, Y. Zhang, Y.-P. Hu, K. Yu, C. Lin, K. McKeehan, J. W. Xuan, D. M. Ornitz, M. M. Shen, et al. Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasis Development, February 15, 2007; 134(4): 723 - 734. [Abstract] [Full Text] [PDF]

				O. B. Goodman Jr., M. Febbraio, R. Simantov, R. Zheng, R. Shen, R. L. Silverstein, and D. M. Nanus Neprilysin Inhibits Angiogenesis via Proteolysis of Fibroblast Growth Factor-2 J. Biol. Chem., November 3, 2006; 281(44): 33597 - 33605. [Abstract] [Full Text] [PDF]

				M. Hatziapostolou, C. Polytarchou, P. Katsoris, J. Courty, and E. Papadimitriou Heparin Affin Regulatory Peptide/Pleiotrophin Mediates Fibroblast Growth Factor 2 Stimulatory Effects on Human Prostate Cancer Cells J. Biol. Chem., October 27, 2006; 281(43): 32217 - 32226. [Abstract] [Full Text] [PDF]

				M. P. Valta, T. Hentunen, Q. Qu, E. M. Valve, A. Harjula, J. A. Seppanen, H. K. Vaananen, and P. L. Harkonen Regulation of Osteoblast Differentiation: A Novel Function for Fibroblast Growth Factor 8 Endocrinology, May 1, 2006; 147(5): 2171 - 2182. [Abstract] [Full Text] [PDF]

				R. Heer, A. T. Collins, C. N. Robson, B. K. Shenton, and H. Y. Leung KGF suppresses {alpha}2{beta}1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epithelium. J. Cell Sci., April 1, 2006; 119(Pt 7): 1416 - 1424. [Abstract] [Full Text] [PDF]

				E. M. Haugsten, V. Sorensen, A. Brech, S. Olsnes, and J. Wesche Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors J. Cell Sci., September 1, 2005; 118(17): 3869 - 3881. [Abstract] [Full Text] [PDF]

				R. St. Bernard, L. Zheng, W. Liu, D. Winer, S. L. Asa, and S. Ezzat Fibroblast Growth Factor Receptors as Molecular Targets in Thyroid Carcinoma Endocrinology, March 1, 2005; 146(3): 1145 - 1153. [Abstract] [Full Text] [PDF]

				U. V. Wesley, M. McGroarty, and A. Homoyouni Dipeptidyl Peptidase Inhibits Malignant Phenotype of Prostate Cancer Cells by Blocking Basic Fibroblast Growth Factor Signaling Pathway Cancer Res., February 15, 2005; 65(4): 1325 - 1334. [Abstract] [Full Text] [PDF]

				B Kwabi-Addo, M Ozen, and M Ittmann The role of fibroblast growth factors and their receptors in prostate cancer Endocr. Relat. Cancer, December 1, 2004; 11(4): 709 - 724. [Abstract] [Full Text] [PDF]

				J. Wang, D. W. Stockton, and M. Ittmann The Fibroblast Growth Factor Receptor-4 Arg388 Allele Is Associated with Prostate Cancer Initiation and Progression Clin. Cancer Res., September 15, 2004; 10(18): 6169 - 6178. [Abstract] [Full Text] [PDF]

				S. Halin, P. Wikstrom, S. H. Rudolfsson, P. Stattin, J. A. Doll, S. E. Crawford, and A. Bergh Decreased Pigment Epithelium-Derived Factor Is Associated with Metastatic Phenotype in Human and Rat Prostate Tumors Cancer Res., August 15, 2004; 64(16): 5664 - 5671. [Abstract] [Full Text] [PDF]

				B. Kwabi-Addo, J. Wang, H. Erdem, A. Vaid, P. Castro, G. Ayala, and M. Ittmann The Expression of Sprouty1, an Inhibitor of Fibroblast Growth Factor Signal Transduction, Is Decreased in Human Prostate Cancer Cancer Res., July 15, 2004; 64(14): 4728 - 4735. [Abstract] [Full Text] [PDF]

				Z. R. Qian, T. Sano, S. L. Asa, S. Yamada, H. Horiguchi, T. Tashiro, C. C. Li, M. Hirokawa, K. Kovacs, and S. Ezzat Cytoplasmic Expression of Fibroblast Growth Factor Receptor-4 in Human Pituitary Adenomas: Relation to Tumor Type, Size, Proliferation, and Invasiveness J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1904 - 1911. [Abstract] [Full Text] [PDF]

				C. Jin, K. McKeehan, W. Guo, S. Jauma, M. M. Ittmann, B. Foster, N. M. Greenberg, W. L. McKeehan, and F. Wang Cooperation between Ectopic FGFR1 and Depression of FGFR2 in Induction of Prostatic Intraepithelial Neoplasia in the Mouse Prostate Cancer Res., December 15, 2003; 63(24): 8784 - 8790. [Abstract] [Full Text] [PDF]

				N. Polnaszek, B. Kwabi-Addo, L. E. Peterson, M. Ozen, N. M. Greenberg, S. Ortega, C. Basilico, and M. Ittmann Fibroblast Growth Factor 2 Promotes Tumor Progression in an Autochthonous Mouse Model of Prostate Cancer Cancer Res., September 15, 2003; 63(18): 5754 - 5760. [Abstract] [Full Text] [PDF]

				A. M. Hinsby, J. V. Olsen, K. L. Bennett, and M. Mann Signaling Initiated by Overexpression of the Fibroblast Growth Factor Receptor-1 Investigated by Mass Spectrometry Mol. Cell. Proteomics, January 1, 2003; 2(1): 29 - 36. [Abstract] [Full Text] [PDF]

				J. A. Tuxhorn, S. J. McAlhany, T. D. Dang, G. E. Ayala, and D. R. Rowley Stromal Cells Promote Angiogenesis and Growth of Human Prostate Tumors in a Differential Reactive Stroma (DRS) Xenograft Model Cancer Res., June 1, 2002; 62(11): 3298 - 3307. [Abstract] [Full Text] [PDF]

				B. E. Welm, K. W. Freeman, M. Chen, A. Contreras, D. M. Spencer, and J. M. Rosen Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland J. Cell Biol., May 13, 2002; 157(4): 703 - 714. [Abstract] [Full Text] [PDF]

				M. Ozen, D. Giri, F. Ropiquet, A. Mansukhani, and M. Ittmann Role of Fibroblast Growth Factor Receptor Signaling in Prostate Cancer Cell Survival J Natl Cancer Inst, December 5, 2001; 93(23): 1783 - 1790. [Abstract] [Full Text] [PDF]

				D. Giri and M. Ittmann Interleukin-8 Is a Paracrine Inducer of Fibroblast Growth Factor 2, a Stromal and Epithelial Growth Factor in Benign Prostatic Hyperplasia Am. J. Pathol., July 1, 2001; 159(1): 139 - 147. [Abstract] [Full Text] [PDF]

				O. N. El-Assal, A. Yamanoi, T. Ono, H. Kohno, and N. Nagasue The Clinicopathological Significance of Heparanase and Basic Fibroblast Growth Factor Expressions in Hepatocellular Carcinoma Clin. Cancer Res., May 1, 2001; 7(5): 1299 - 1305. [Abstract] [Full Text]

				R. T.-P. Poon, S.-T. Fan, and J. Wong Clinical Implications of Circulating Angiogenic Factors in Cancer Patients J. Clin. Oncol., February 15, 2001; 19(4): 1207 - 1225. [Abstract] [Full Text] [PDF]

				M. P. V. Shekhar, J. Werdell, S. J. Santner, R. J. Pauley, and L. Tait Breast Stroma Plays a Dominant Regulatory Role in Breast Epithelial Growth and Differentiation: Implications for Tumor Development and Progression Cancer Res., February 1, 2001; 61(4): 1320 - 1326. [Abstract] [Full Text]

				F. Ropiquet, D. Giri, B. Kwabi-Addo, A. Mansukhani, and M. Ittmann Increased Expression of Fibroblast Growth Factor 6 in Human Prostatic Intraepithelial Neoplasia and Prostate Cancer Cancer Res., August 1, 2000; 60(15): 4245 - 4250. [Abstract] [Full Text]

				D. Giri and M. Ittmann Interleukin-1{alpha} Is a Paracrine Inducer of FGF7, a Key Epithelial Growth Factor in Benign Prostatic Hyperplasia Am. J. Pathol., July 1, 2000; 157(1): 249 - 255. [Abstract] [Full Text] [PDF]

				F. Moinfar, Y. G. Man, L. Arnould, G. L. Bratthauer, M. Ratschek, and F. A. Tavassoli Concurrent and Independent Genetic Alterations in the Stromal and Epithelial Cells of Mammary Carcinoma: Implications for Tumorigenesis Cancer Res., May 1, 2000; 60(9): 2562 - 2566. [Abstract] [Full Text]

				E. Shimizu-Sasaki, M. Yamazaki, S. Furuyama, H. Sugiya, J. Sodek, and Y. Ogata Identification of a Novel Response Element in the Rat Bone Sialoprotein (BSP) Gene Promoter that Mediates Constitutive and Fibroblast Growth Factor 2-induced Expression of BSP J. Biol. Chem., February 16, 2001; 276(8): 5459 - 5466. [Abstract] [Full Text] [PDF]